

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.73955917 |
| 2 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.78579686 |
| 3 | DNA deamination (GO:0045006) | 4.77625437 |
| 4 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.47099119 |
| 5 | DNA strand elongation (GO:0022616) | 4.35973805 |
| 6 | cotranslational protein targeting to membrane (GO:0006613) | 4.33175407 |
| 7 | protein targeting to ER (GO:0045047) | 4.33066373 |
| 8 | viral transcription (GO:0019083) | 4.32455948 |
| 9 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.25094626 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.24998545 |
| 11 | pentose-phosphate shunt (GO:0006098) | 4.23076938 |
| 12 | translational termination (GO:0006415) | 4.22820593 |
| 13 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.13779288 |
| 14 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.11982185 |
| 15 | protein localization to endoplasmic reticulum (GO:0070972) | 4.08827632 |
| 16 | pinocytosis (GO:0006907) | 4.06176135 |
| 17 | formation of translation preinitiation complex (GO:0001731) | 4.04309684 |
| 18 | translational elongation (GO:0006414) | 3.94743404 |
| 19 | NADPH regeneration (GO:0006740) | 3.90722166 |
| 20 | protein retention in ER lumen (GO:0006621) | 3.90423560 |
| 21 | IMP biosynthetic process (GO:0006188) | 3.87054030 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.86910460 |
| 23 | barbed-end actin filament capping (GO:0051016) | 3.82028791 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 3.80562334 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 3.80562334 |
| 26 | telomere maintenance via telomere lengthening (GO:0010833) | 3.73539574 |
| 27 | glucose catabolic process (GO:0006007) | 3.65835164 |
| 28 | nucleotide salvage (GO:0043173) | 3.61386545 |
| 29 | telomere maintenance via recombination (GO:0000722) | 3.61257430 |
| 30 | maturation of SSU-rRNA (GO:0030490) | 3.59823307 |
| 31 | translational initiation (GO:0006413) | 3.53685367 |
| 32 | ribosomal small subunit biogenesis (GO:0042274) | 3.52628013 |
| 33 | IMP metabolic process (GO:0046040) | 3.52551618 |
| 34 | translation (GO:0006412) | 3.52521626 |
| 35 | exocrine pancreas development (GO:0031017) | 3.49958930 |
| 36 | oxidative phosphorylation (GO:0006119) | 3.47414016 |
| 37 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.39856995 |
| 38 | DNA replication initiation (GO:0006270) | 3.38839446 |
| 39 | monosaccharide biosynthetic process (GO:0046364) | 3.37613031 |
| 40 | ribosomal large subunit biogenesis (GO:0042273) | 3.35906457 |
| 41 | viral life cycle (GO:0019058) | 3.31681189 |
| 42 | mitotic recombination (GO:0006312) | 3.29660075 |
| 43 | signal peptide processing (GO:0006465) | 3.29619617 |
| 44 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.26650228 |
| 45 | cellular protein complex disassembly (GO:0043624) | 3.24669645 |
| 46 | GDP-mannose metabolic process (GO:0019673) | 3.23333212 |
| 47 | purine nucleotide salvage (GO:0032261) | 3.21132203 |
| 48 | DNA unwinding involved in DNA replication (GO:0006268) | 3.20830071 |
| 49 | gluconeogenesis (GO:0006094) | 3.20822853 |
| 50 | UV protection (GO:0009650) | 3.19784207 |
| 51 | tricarboxylic acid cycle (GO:0006099) | 3.18299963 |
| 52 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.17188014 |
| 53 | glycolytic process (GO:0006096) | 3.16100876 |
| 54 | DNA replication checkpoint (GO:0000076) | 3.15607889 |
| 55 | nucleobase biosynthetic process (GO:0046112) | 3.15467519 |
| 56 | mitochondrial calcium ion transport (GO:0006851) | 3.15408068 |
| 57 | pentose metabolic process (GO:0019321) | 3.14086170 |
| 58 | pyrimidine-containing compound salvage (GO:0008655) | 3.13438351 |
| 59 | pyrimidine nucleoside salvage (GO:0043097) | 3.13438351 |
| 60 | ubiquinone biosynthetic process (GO:0006744) | 3.12864016 |
| 61 | quinone biosynthetic process (GO:1901663) | 3.12864016 |
| 62 | glucose 6-phosphate metabolic process (GO:0051156) | 3.09829136 |
| 63 | hexose biosynthetic process (GO:0019319) | 3.09134209 |
| 64 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.08498080 |
| 65 | 4-hydroxyproline metabolic process (GO:0019471) | 3.07423516 |
| 66 | mitotic nuclear envelope reassembly (GO:0007084) | 3.06793197 |
| 67 | nuclear envelope reassembly (GO:0031468) | 3.06793197 |
| 68 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.03696772 |
| 69 | muscle filament sliding (GO:0030049) | 3.03264492 |
| 70 | actin-myosin filament sliding (GO:0033275) | 3.03264492 |
| 71 | response to peptidoglycan (GO:0032494) | 3.02964568 |
| 72 | spliceosomal snRNP assembly (GO:0000387) | 3.01270600 |
| 73 | cullin deneddylation (GO:0010388) | 3.00958676 |
| 74 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.96587141 |
| 75 | pseudouridine synthesis (GO:0001522) | 2.96483324 |
| 76 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.94771595 |
| 77 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.94618508 |
| 78 | regulation of mitochondrial translation (GO:0070129) | 2.93169142 |
| 79 | protein complex disassembly (GO:0043241) | 2.92613090 |
| 80 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.92279217 |
| 81 | deoxyribonucleotide catabolic process (GO:0009264) | 2.91008657 |
| 82 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.90446824 |
| 83 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.89629544 |
| 84 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.89629544 |
| 85 | telomere maintenance via telomerase (GO:0007004) | 2.89387458 |
| 86 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.89278036 |
| 87 | protein localization to kinetochore (GO:0034501) | 2.87988703 |
| 88 | protein deneddylation (GO:0000338) | 2.85739886 |
| 89 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.82236660 |
| 90 | metallo-sulfur cluster assembly (GO:0031163) | 2.81816775 |
| 91 | iron-sulfur cluster assembly (GO:0016226) | 2.81816775 |
| 92 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.81613447 |
| 93 | prostanoid biosynthetic process (GO:0046457) | 2.81553912 |
| 94 | prostaglandin biosynthetic process (GO:0001516) | 2.81553912 |
| 95 | regulation of superoxide anion generation (GO:0032928) | 2.81446063 |
| 96 | purine nucleobase biosynthetic process (GO:0009113) | 2.80870907 |
| 97 | deoxyribose phosphate catabolic process (GO:0046386) | 2.80660538 |
| 98 | macromolecular complex disassembly (GO:0032984) | 2.80182922 |
| 99 | protein targeting to membrane (GO:0006612) | 2.78249005 |
| 100 | peptidyl-histidine modification (GO:0018202) | 2.77251877 |
| 101 | oxaloacetate metabolic process (GO:0006107) | 2.76309793 |
| 102 | heart contraction (GO:0060047) | 2.76051272 |
| 103 | heart process (GO:0003015) | 2.76051272 |
| 104 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.75809420 |
| 105 | NADH metabolic process (GO:0006734) | 2.73474306 |
| 106 | tricarboxylic acid metabolic process (GO:0072350) | 2.73442713 |
| 107 | proteasome assembly (GO:0043248) | 2.73213691 |
| 108 | nucleoside salvage (GO:0043174) | 2.71803437 |
| 109 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.71356240 |
| 110 | negative regulation of B cell apoptotic process (GO:0002903) | 2.70756834 |
| 111 | ATP synthesis coupled proton transport (GO:0015986) | 2.69916612 |
| 112 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.69916612 |
| 113 | RNA-dependent DNA replication (GO:0006278) | 2.69717102 |
| 114 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.68916290 |
| 115 | telomere organization (GO:0032200) | 2.68750832 |
| 116 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.68230231 |
| 117 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.67877472 |
| 118 | telomere maintenance (GO:0000723) | 2.67845880 |
| 119 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.67612593 |
| 120 | termination of RNA polymerase III transcription (GO:0006386) | 2.67612593 |
| 121 | protein maturation by protein folding (GO:0022417) | 2.66986085 |
| 122 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.66678206 |
| 123 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.66202613 |
| 124 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.65710147 |
| 125 | negative regulation of ligase activity (GO:0051352) | 2.65710147 |
| 126 | mitochondrial fusion (GO:0008053) | 2.65642033 |
| 127 | galactose catabolic process (GO:0019388) | 2.65361993 |
| 128 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.64275275 |
| 129 | proline biosynthetic process (GO:0006561) | 2.63727062 |
| 130 | CENP-A containing nucleosome assembly (GO:0034080) | 2.63060249 |
| 131 | establishment of viral latency (GO:0019043) | 2.61777957 |
| 132 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.61733670 |
| 133 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.61495814 |
| 134 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.61480381 |
| 135 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58359687 |
| 136 | valine metabolic process (GO:0006573) | 2.58097835 |
| 137 | histone arginine methylation (GO:0034969) | 2.57841424 |
| 138 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.56510940 |
| 139 | ubiquinone metabolic process (GO:0006743) | 2.55499997 |
| 140 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.55434499 |
| 141 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.55376296 |
| 142 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.55376296 |
| 143 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.54487732 |
| 144 | rRNA processing (GO:0006364) | 2.54354911 |
| 145 | chromatin remodeling at centromere (GO:0031055) | 2.51601585 |
| 146 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.49393167 |
| 147 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.47947589 |
| 148 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.44576536 |
| 149 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.44576536 |
| 150 | cellular metabolic compound salvage (GO:0043094) | 2.42442362 |
| 151 | base-excision repair, AP site formation (GO:0006285) | 2.42090811 |
| 152 | amino sugar catabolic process (GO:0046348) | 2.41813655 |
| 153 | fructose metabolic process (GO:0006000) | 2.41018771 |
| 154 | pyruvate metabolic process (GO:0006090) | 2.38726679 |
| 155 | peptidyl-arginine methylation (GO:0018216) | 2.38460599 |
| 156 | peptidyl-arginine N-methylation (GO:0035246) | 2.38460599 |
| 157 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.36793676 |
| 158 | glycosphingolipid catabolic process (GO:0046479) | 2.36299686 |
| 159 | cyclooxygenase pathway (GO:0019371) | 2.36100508 |
| 160 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.35400964 |
| 161 | proline metabolic process (GO:0006560) | 2.34704374 |
| 162 | protein targeting to mitochondrion (GO:0006626) | 2.34623249 |
| 163 | hyaluronan catabolic process (GO:0030214) | 2.32835532 |
| 164 | peptidyl-proline hydroxylation (GO:0019511) | 2.32588065 |
| 165 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.32276393 |
| 166 | regulation of mitochondrial membrane potential (GO:0051881) | 2.32161509 |
| 167 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.31292199 |
| 168 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.29847739 |
| 169 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.28226053 |
| 170 | purine nucleobase metabolic process (GO:0006144) | 2.27799229 |
| 171 | NADP metabolic process (GO:0006739) | 2.26708818 |
| 172 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.25356966 |
| 173 | AMP metabolic process (GO:0046033) | 2.24428380 |
| 174 | L-phenylalanine metabolic process (GO:0006558) | 2.24178740 |
| 175 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.24178740 |
| 176 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.24158868 |
| 177 | deoxyribose phosphate metabolic process (GO:0019692) | 2.21901996 |
| 178 | negative regulation of mitochondrion organization (GO:0010823) | 2.21137414 |
| 179 | protein localization to endosome (GO:0036010) | 2.21118738 |
| 180 | extracellular fibril organization (GO:0043206) | 2.20898809 |
| 181 | L-serine metabolic process (GO:0006563) | 2.19247445 |
| 182 | response to thyroid hormone (GO:0097066) | 2.18565393 |
| 183 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.17328198 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.84859379 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.06952478 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.84678580 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.35092244 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.12301848 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95027226 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.94519923 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.90589911 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.80863356 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.80530852 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.78431033 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.76475626 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.58887662 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.56929410 |
| 15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.52883006 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.37715543 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.36994510 |
| 18 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.34205931 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.31156766 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.25560209 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.15452709 |
| 22 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.14712459 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.12185283 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.11001566 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.09568643 |
| 26 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.08505242 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.06532046 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.06136528 |
| 29 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05554395 |
| 30 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.01451964 |
| 31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.96499102 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96187367 |
| 33 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.94674213 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.92449989 |
| 35 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.90726823 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.90649072 |
| 37 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87307821 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.84151168 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80824367 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.79012815 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.77010651 |
| 42 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.75619789 |
| 43 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.70867698 |
| 44 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70803987 |
| 45 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.70642930 |
| 46 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.68969862 |
| 47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68692598 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.68010712 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.67678882 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.67056241 |
| 51 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.64547229 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63704358 |
| 53 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.59272510 |
| 54 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58818366 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.58278174 |
| 56 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.57887046 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.57474404 |
| 58 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56886347 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.48766389 |
| 60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.44129371 |
| 61 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.43385019 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42115831 |
| 63 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.41613941 |
| 64 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.41467767 |
| 65 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.41406994 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41405605 |
| 67 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.40870170 |
| 68 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.40744563 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40117753 |
| 70 | * P68_20966046_ChIP-Seq_HELA_Human | 1.38654676 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.36778829 |
| 72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.36551972 |
| 73 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.34632119 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32779137 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.31766073 |
| 76 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31709999 |
| 77 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30302196 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.29153030 |
| 79 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29122242 |
| 80 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28335206 |
| 81 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.28296770 |
| 82 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.28204349 |
| 83 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27678579 |
| 84 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27082007 |
| 85 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24034494 |
| 86 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.22520383 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.22334320 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22067001 |
| 89 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21728097 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21519241 |
| 91 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20014204 |
| 92 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.19385771 |
| 93 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.17831213 |
| 94 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17040335 |
| 95 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.17017981 |
| 96 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16111325 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15776072 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15447145 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.14681284 |
| 100 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13990977 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13636341 |
| 102 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12922731 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12712938 |
| 104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.11505990 |
| 105 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.09551929 |
| 106 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08650665 |
| 107 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.08453700 |
| 108 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08380418 |
| 109 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08193033 |
| 110 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.07977461 |
| 111 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07813502 |
| 112 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07576830 |
| 113 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.06620280 |
| 114 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04964306 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04893929 |
| 116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.04454586 |
| 117 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04408585 |
| 118 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04080893 |
| 119 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03896739 |
| 120 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03605904 |
| 121 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03356608 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03340027 |
| 123 | * MAF_26560356_Chip-Seq_TH2_Human | 1.03199738 |
| 124 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03155662 |
| 125 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.02594789 |
| 126 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02482910 |
| 127 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02435235 |
| 128 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00365748 |
| 129 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99611691 |
| 130 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99494606 |
| 131 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98747222 |
| 132 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.94364503 |
| 133 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.93710421 |
| 134 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.92731790 |
| 135 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91724385 |
| 136 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89130621 |
| 137 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87100318 |
| 138 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85598524 |
| 139 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.85331609 |
| 140 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84844062 |
| 141 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.83927875 |
| 142 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83385856 |
| 143 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82911898 |
| 144 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81875681 |
| 145 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.81515425 |
| 146 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.78536012 |
| 147 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.78324624 |
| 148 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.77863699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005451_abnormal_body_composition | 3.48674458 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.42448019 |
| 3 | MP0008260_abnormal_autophagy | 3.35018643 |
| 4 | MP0009840_abnormal_foam_cell | 3.32310008 |
| 5 | MP0000749_muscle_degeneration | 2.73605646 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.73177982 |
| 7 | MP0004957_abnormal_blastocyst_morpholog | 2.63640645 |
| 8 | MP0009278_abnormal_bone_marrow | 2.56907250 |
| 9 | MP0003111_abnormal_nucleus_morphology | 2.51959510 |
| 10 | MP0010094_abnormal_chromosome_stability | 2.50109790 |
| 11 | MP0005220_abnormal_exocrine_pancreas | 2.46685153 |
| 12 | MP0004858_abnormal_nervous_system | 2.33178953 |
| 13 | MP0003646_muscle_fatigue | 2.33051695 |
| 14 | MP0006054_spinal_hemorrhage | 2.32407203 |
| 15 | MP0003077_abnormal_cell_cycle | 2.27937593 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.18633034 |
| 17 | MP0006036_abnormal_mitochondrial_physio | 2.18069268 |
| 18 | MP0000490_abnormal_crypts_of | 2.16599743 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.15263248 |
| 20 | MP0004084_abnormal_cardiac_muscle | 2.13472454 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.03233774 |
| 22 | MP0003436_decreased_susceptibility_to | 1.89648154 |
| 23 | MP0004510_myositis | 1.87795844 |
| 24 | MP0000750_abnormal_muscle_regeneration | 1.86903536 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.85671931 |
| 26 | MP0008058_abnormal_DNA_repair | 1.85462849 |
| 27 | MP0000751_myopathy | 1.84700967 |
| 28 | MP0003075_altered_response_to | 1.80208133 |
| 29 | MP0005464_abnormal_platelet_physiology | 1.79756752 |
| 30 | MP0008007_abnormal_cellular_replicative | 1.73196774 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.71835181 |
| 32 | MP0005330_cardiomyopathy | 1.69167239 |
| 33 | MP0003123_paternal_imprinting | 1.63091116 |
| 34 | MP0004036_abnormal_muscle_relaxation | 1.61150926 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.60381833 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.59510600 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.55731732 |
| 38 | MP0002269_muscular_atrophy | 1.55705146 |
| 39 | MP0003279_aneurysm | 1.54035815 |
| 40 | MP0001849_ear_inflammation | 1.49856765 |
| 41 | MP0005083_abnormal_biliary_tract | 1.48944426 |
| 42 | MP0003828_pulmonary_edema | 1.47730250 |
| 43 | MP0003186_abnormal_redox_activity | 1.46050989 |
| 44 | MP0003763_abnormal_thymus_physiology | 1.45514482 |
| 45 | MP0008932_abnormal_embryonic_tissue | 1.44753902 |
| 46 | MP0009379_abnormal_foot_pigmentation | 1.44704417 |
| 47 | MP0003567_abnormal_fetal_cardiomyocyte | 1.43578067 |
| 48 | MP0004147_increased_porphyrin_level | 1.40829623 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.38936048 |
| 50 | MP0003221_abnormal_cardiomyocyte_apopto | 1.38787201 |
| 51 | MP0004215_abnormal_myocardial_fiber | 1.38185854 |
| 52 | MP0002106_abnormal_muscle_physiology | 1.36469620 |
| 53 | MP0004087_abnormal_muscle_fiber | 1.35493274 |
| 54 | MP0005257_abnormal_intraocular_pressure | 1.35067566 |
| 55 | * MP0004233_abnormal_muscle_weight | 1.33242732 |
| 56 | MP0002419_abnormal_innate_immunity | 1.32917139 |
| 57 | MP0003303_peritoneal_inflammation | 1.28268889 |
| 58 | MP0002693_abnormal_pancreas_physiology | 1.27769369 |
| 59 | MP0008057_abnormal_DNA_replication | 1.24661309 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.23467960 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.19850930 |
| 62 | MP0008438_abnormal_cutaneous_collagen | 1.19582719 |
| 63 | MP0005501_abnormal_skin_physiology | 1.16621680 |
| 64 | MP0005023_abnormal_wound_healing | 1.16605828 |
| 65 | MP0000678_abnormal_parathyroid_gland | 1.14706243 |
| 66 | MP0010630_abnormal_cardiac_muscle | 1.13921209 |
| 67 | MP0000747_muscle_weakness | 1.13747343 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11235393 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.10104840 |
| 70 | MP0005025_abnormal_response_to | 1.09584998 |
| 71 | MP0004272_abnormal_basement_membrane | 1.09045299 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 1.07654931 |
| 73 | MP0002019_abnormal_tumor_incidence | 1.07213344 |
| 74 | MP0005369_muscle_phenotype | 1.06282756 |
| 75 | MP0000313_abnormal_cell_death | 1.06193614 |
| 76 | MP0005385_cardiovascular_system_phenoty | 1.05835187 |
| 77 | MP0001544_abnormal_cardiovascular_syste | 1.05835187 |
| 78 | MP0001881_abnormal_mammary_gland | 1.05745472 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 1.05520036 |
| 80 | MP0001835_abnormal_antigen_presentation | 1.04684329 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 1.03064159 |
| 82 | MP0001730_embryonic_growth_arrest | 1.02811129 |
| 83 | MP0000343_altered_response_to | 1.02502418 |
| 84 | MP0001873_stomach_inflammation | 1.01822131 |
| 85 | MP0002132_abnormal_respiratory_system | 1.01553898 |
| 86 | MP0005620_abnormal_muscle_contractility | 1.01043127 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 1.00227790 |
| 88 | MP0002796_impaired_skin_barrier | 0.99676911 |
| 89 | MP0000350_abnormal_cell_proliferation | 0.99318055 |
| 90 | MP0008469_abnormal_protein_level | 0.98557460 |
| 91 | MP0010030_abnormal_orbit_morphology | 0.98367967 |
| 92 | MP0003806_abnormal_nucleotide_metabolis | 0.98203692 |
| 93 | MP0002080_prenatal_lethality | 0.97802184 |
| 94 | MP0003300_gastrointestinal_ulcer | 0.95915554 |
| 95 | MP0003786_premature_aging | 0.95889281 |
| 96 | MP0002972_abnormal_cardiac_muscle | 0.94407152 |
| 97 | MP0001697_abnormal_embryo_size | 0.93541074 |
| 98 | MP0005670_abnormal_white_adipose | 0.91828158 |
| 99 | MP0009785_altered_susceptibility_to | 0.91585146 |
| 100 | MP0008004_abnormal_stomach_pH | 0.91331638 |
| 101 | MP0002722_abnormal_immune_system | 0.91315528 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.90827055 |
| 103 | MP0009764_decreased_sensitivity_to | 0.90575326 |
| 104 | MP0005166_decreased_susceptibility_to | 0.89419550 |
| 105 | MP0001944_abnormal_pancreas_morphology | 0.89277611 |
| 106 | MP0002398_abnormal_bone_marrow | 0.87861852 |
| 107 | MP0000689_abnormal_spleen_morphology | 0.87321264 |
| 108 | MP0000858_altered_metastatic_potential | 0.87174778 |
| 109 | MP0000703_abnormal_thymus_morphology | 0.86938659 |
| 110 | MP0001853_heart_inflammation | 0.83487455 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.82982372 |
| 112 | MP0005360_urolithiasis | 0.82782198 |
| 113 | MP0001542_abnormal_bone_strength | 0.82299734 |
| 114 | MP0000358_abnormal_cell_content/ | 0.82218919 |
| 115 | MP0005671_abnormal_response_to | 0.81017896 |
| 116 | MP0002429_abnormal_blood_cell | 0.80184339 |
| 117 | MP0001661_extended_life_span | 0.79921947 |
| 118 | MP0002332_abnormal_exercise_endurance | 0.79597194 |
| 119 | MP0004043_abnormal_pH_regulation | 0.79519081 |
| 120 | MP0005390_skeleton_phenotype | 0.79183559 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.79168836 |
| 122 | MP0004130_abnormal_muscle_cell | 0.78442868 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.77703449 |
| 124 | MP0003984_embryonic_growth_retardation | 0.77538605 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.76413645 |
| 126 | MP0005165_increased_susceptibility_to | 0.76114013 |
| 127 | MP0000685_abnormal_immune_system | 0.76105361 |
| 128 | MP0002088_abnormal_embryonic_growth/wei | 0.76005797 |
| 129 | MP0003724_increased_susceptibility_to | 0.75316123 |
| 130 | MP0010352_gastrointestinal_tract_polyps | 0.75129561 |
| 131 | MP0005058_abnormal_lysosome_morphology | 0.74661020 |
| 132 | MP0001545_abnormal_hematopoietic_system | 0.74504604 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.74504604 |
| 134 | MP0002638_abnormal_pupillary_reflex | 0.73901618 |
| 135 | MP0000013_abnormal_adipose_tissue | 0.73834894 |
| 136 | MP0000604_amyloidosis | 0.73796580 |
| 137 | MP0008775_abnormal_heart_ventricle | 0.73490084 |
| 138 | MP0001727_abnormal_embryo_implantation | 0.73438494 |
| 139 | MP0008874_decreased_physiological_sensi | 0.72991606 |
| 140 | MP0010155_abnormal_intestine_physiology | 0.72600931 |
| 141 | MP0005623_abnormal_meninges_morphology | 0.71945241 |
| 142 | MP0009643_abnormal_urine_homeostasis | 0.71815910 |
| 143 | MP0001986_abnormal_taste_sensitivity | 0.71572846 |
| 144 | MP0001764_abnormal_homeostasis | 0.71405810 |
| 145 | * MP0005375_adipose_tissue_phenotype | 0.71062439 |
| 146 | MP0001672_abnormal_embryogenesis/_devel | 0.70433966 |
| 147 | MP0005380_embryogenesis_phenotype | 0.70433966 |
| 148 | MP0002089_abnormal_postnatal_growth/wei | 0.70333245 |
| 149 | MP0005666_abnormal_adipose_tissue | 0.70311660 |
| 150 | MP0009763_increased_sensitivity_to | 0.70117841 |
| 151 | MP0002148_abnormal_hypersensitivity_rea | 0.69986120 |
| 152 | MP0000609_abnormal_liver_physiology | 0.68975400 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.67932357 |
| 154 | MP0005000_abnormal_immune_tolerance | 0.67590087 |
| 155 | * MP0000003_abnormal_adipose_tissue | 0.67472749 |
| 156 | MP0002822_catalepsy | 0.67232811 |
| 157 | MP0005621_abnormal_cell_physiology | 0.67116386 |
| 158 | MP0000767_abnormal_smooth_muscle | 0.66977151 |
| 159 | MP0005384_cellular_phenotype | 0.66831275 |
| 160 | MP0003329_amyloid_beta_deposits | 0.66379037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 4.05191794 |
| 2 | Cholecystitis (HP:0001082) | 4.03632644 |
| 3 | Abnormal gallbladder physiology (HP:0012438) | 4.03632644 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 3.96250992 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.96250992 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.96250992 |
| 7 | Aplastic anemia (HP:0001915) | 3.77102455 |
| 8 | Hepatic necrosis (HP:0002605) | 3.67910118 |
| 9 | Myoglobinuria (HP:0002913) | 3.54473668 |
| 10 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.54334248 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 3.42240745 |
| 12 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.41088972 |
| 13 | Vertebral compression fractures (HP:0002953) | 3.35873384 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.33101061 |
| 15 | Distal lower limb muscle weakness (HP:0009053) | 3.23787306 |
| 16 | Rhabdomyolysis (HP:0003201) | 3.16455563 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.16033491 |
| 18 | Exercise-induced muscle cramps (HP:0003710) | 3.12925430 |
| 19 | Mitochondrial inheritance (HP:0001427) | 3.04905120 |
| 20 | Acute necrotizing encephalopathy (HP:0006965) | 3.04078164 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.00185507 |
| 22 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.00185507 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 2.99351638 |
| 24 | Progressive muscle weakness (HP:0003323) | 2.94708315 |
| 25 | Increased CSF lactate (HP:0002490) | 2.91440825 |
| 26 | Muscle fiber inclusion bodies (HP:0100299) | 2.83307849 |
| 27 | Exercise intolerance (HP:0003546) | 2.81639355 |
| 28 | Thrombocytosis (HP:0001894) | 2.79144437 |
| 29 | Calf muscle hypertrophy (HP:0008981) | 2.77564787 |
| 30 | Myopathic facies (HP:0002058) | 2.76237222 |
| 31 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.75660653 |
| 32 | Increased muscle lipid content (HP:0009058) | 2.73375663 |
| 33 | Petechiae (HP:0000967) | 2.72663196 |
| 34 | Vacuolated lymphocytes (HP:0001922) | 2.71607963 |
| 35 | Birth length less than 3rd percentile (HP:0003561) | 2.71499235 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.71394545 |
| 37 | Rough bone trabeculation (HP:0100670) | 2.70324792 |
| 38 | Axonal loss (HP:0003447) | 2.69250061 |
| 39 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.68535891 |
| 40 | Abnormal protein glycosylation (HP:0012346) | 2.68172922 |
| 41 | Abnormal glycosylation (HP:0012345) | 2.68172922 |
| 42 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.68172922 |
| 43 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.68172922 |
| 44 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.67913378 |
| 45 | Systemic lupus erythematosus (HP:0002725) | 2.67245027 |
| 46 | Hepatosplenomegaly (HP:0001433) | 2.67110609 |
| 47 | Achilles tendon contracture (HP:0001771) | 2.66489311 |
| 48 | Ventricular tachycardia (HP:0004756) | 2.65025450 |
| 49 | Nemaline bodies (HP:0003798) | 2.64729587 |
| 50 | Dysostosis multiplex (HP:0000943) | 2.63843560 |
| 51 | Subaortic stenosis (HP:0001682) | 2.60973891 |
| 52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.60973891 |
| 53 | Exercise-induced myalgia (HP:0003738) | 2.59486664 |
| 54 | Increased serum lactate (HP:0002151) | 2.58844130 |
| 55 | Acute encephalopathy (HP:0006846) | 2.56365456 |
| 56 | Hypertensive crisis (HP:0100735) | 2.56060031 |
| 57 | Lactic acidosis (HP:0003128) | 2.55854831 |
| 58 | Abnormality of glycolysis (HP:0004366) | 2.54746643 |
| 59 | Lipoatrophy (HP:0100578) | 2.52395689 |
| 60 | Palpitations (HP:0001962) | 2.51834498 |
| 61 | Increased intramyocellular lipid droplets (HP:0012240) | 2.51480681 |
| 62 | Prolonged neonatal jaundice (HP:0006579) | 2.50358099 |
| 63 | Opisthotonus (HP:0002179) | 2.49982438 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 2.48909004 |
| 65 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.48421646 |
| 66 | Abnormality of alanine metabolism (HP:0010916) | 2.48421646 |
| 67 | Hyperalaninemia (HP:0003348) | 2.48421646 |
| 68 | Purpura (HP:0000979) | 2.46438202 |
| 69 | Muscle stiffness (HP:0003552) | 2.37064646 |
| 70 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.36692957 |
| 71 | Generalized amyotrophy (HP:0003700) | 2.35759016 |
| 72 | Premature rupture of membranes (HP:0001788) | 2.30553513 |
| 73 | Loss of speech (HP:0002371) | 2.29235188 |
| 74 | Cholelithiasis (HP:0001081) | 2.29060111 |
| 75 | Oral leukoplakia (HP:0002745) | 2.28678940 |
| 76 | Pancytopenia (HP:0001876) | 2.28265037 |
| 77 | Type 1 muscle fiber predominance (HP:0003803) | 2.28229340 |
| 78 | Bulbar palsy (HP:0001283) | 2.27918152 |
| 79 | Progressive macrocephaly (HP:0004481) | 2.27316150 |
| 80 | Microretrognathia (HP:0000308) | 2.26499387 |
| 81 | Increased connective tissue (HP:0009025) | 2.24824709 |
| 82 | Testicular atrophy (HP:0000029) | 2.22419030 |
| 83 | Increased variability in muscle fiber diameter (HP:0003557) | 2.21185728 |
| 84 | Reduced antithrombin III activity (HP:0001976) | 2.20277090 |
| 85 | Dilated cardiomyopathy (HP:0001644) | 2.18895104 |
| 86 | Lipid accumulation in hepatocytes (HP:0006561) | 2.18839114 |
| 87 | Hypoplasia of the pons (HP:0012110) | 2.18590097 |
| 88 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.18377512 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.18377512 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.18377512 |
| 91 | Neoplasm of head and neck (HP:0012288) | 2.17639928 |
| 92 | Esophageal neoplasm (HP:0100751) | 2.17639928 |
| 93 | Abnormality of macrophages (HP:0004311) | 2.17004227 |
| 94 | Increased serum pyruvate (HP:0003542) | 2.16846671 |
| 95 | Multiple enchondromatosis (HP:0005701) | 2.14183012 |
| 96 | Pallor (HP:0000980) | 2.11373676 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 2.10343673 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.10343673 |
| 99 | Increased cerebral lipofuscin (HP:0011813) | 2.09816493 |
| 100 | Distal lower limb amyotrophy (HP:0008944) | 2.09483173 |
| 101 | Distal arthrogryposis (HP:0005684) | 2.08903288 |
| 102 | Ragged-red muscle fibers (HP:0003200) | 2.08082028 |
| 103 | Macrocytic anemia (HP:0001972) | 2.07447088 |
| 104 | Respiratory failure (HP:0002878) | 2.06396006 |
| 105 | Sudden death (HP:0001699) | 2.04882237 |
| 106 | Asymmetric septal hypertrophy (HP:0001670) | 2.04685811 |
| 107 | Trismus (HP:0000211) | 2.04172504 |
| 108 | Degeneration of anterior horn cells (HP:0002398) | 2.01230238 |
| 109 | Abnormality of the anterior horn cell (HP:0006802) | 2.01230238 |
| 110 | Increased hepatocellular lipid droplets (HP:0006565) | 2.01174797 |
| 111 | Ulnar deviation of the wrist (HP:0003049) | 2.00964658 |
| 112 | Respiratory difficulties (HP:0002880) | 2.00413992 |
| 113 | Exertional dyspnea (HP:0002875) | 1.99800838 |
| 114 | Conjunctival hamartoma (HP:0100780) | 1.97441360 |
| 115 | Calcaneovalgus deformity (HP:0001848) | 1.97281149 |
| 116 | Amyloidosis (HP:0011034) | 1.97083359 |
| 117 | Hypoglycemic coma (HP:0001325) | 1.95320691 |
| 118 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.95030546 |
| 119 | Hypokinesia (HP:0002375) | 1.94464968 |
| 120 | Carpal bone hypoplasia (HP:0001498) | 1.92890311 |
| 121 | Progressive neurologic deterioration (HP:0002344) | 1.92565682 |
| 122 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.92432258 |
| 123 | IgM deficiency (HP:0002850) | 1.92365679 |
| 124 | Abnormal gallbladder morphology (HP:0012437) | 1.92070014 |
| 125 | Mucopolysacchariduria (HP:0008155) | 1.91628896 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.91628896 |
| 127 | 11 pairs of ribs (HP:0000878) | 1.91414569 |
| 128 | EMG: myopathic abnormalities (HP:0003458) | 1.90729691 |
| 129 | Abnormal trabecular bone morphology (HP:0100671) | 1.90052361 |
| 130 | Bone marrow hypocellularity (HP:0005528) | 1.89055353 |
| 131 | Abnormality of the pons (HP:0007361) | 1.87649490 |
| 132 | Increased serum ferritin (HP:0003281) | 1.87600645 |
| 133 | Nausea (HP:0002018) | 1.86916285 |
| 134 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.86841339 |
| 135 | Protrusio acetabuli (HP:0003179) | 1.85905695 |
| 136 | Absent thumb (HP:0009777) | 1.85772265 |
| 137 | Deformed tarsal bones (HP:0008119) | 1.85632297 |
| 138 | Upper motor neuron abnormality (HP:0002127) | 1.85607448 |
| 139 | Nuclear cataract (HP:0100018) | 1.84969173 |
| 140 | Cerebral palsy (HP:0100021) | 1.84578608 |
| 141 | Microvesicular hepatic steatosis (HP:0001414) | 1.83242397 |
| 142 | Myotonia (HP:0002486) | 1.82428934 |
| 143 | Abnormality of the tricuspid valve (HP:0001702) | 1.81046046 |
| 144 | Hyperacusis (HP:0010780) | 1.80959711 |
| 145 | Spinal rigidity (HP:0003306) | 1.80946735 |
| 146 | Obstructive lung disease (HP:0006536) | 1.80437748 |
| 147 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80437748 |
| 148 | Premature graying of hair (HP:0002216) | 1.80436953 |
| 149 | Abnormality of the umbilical cord (HP:0010881) | 1.80431825 |
| 150 | 3-Methylglutaconic aciduria (HP:0003535) | 1.80398461 |
| 151 | Cellulitis (HP:0100658) | 1.78394732 |
| 152 | Abnormality of T cell physiology (HP:0011840) | 1.78153040 |
| 153 | Myocardial infarction (HP:0001658) | 1.76161088 |
| 154 | Neck muscle weakness (HP:0000467) | 1.76074925 |
| 155 | Muscle fiber splitting (HP:0003555) | 1.75408161 |
| 156 | Easy fatigability (HP:0003388) | 1.75299603 |
| 157 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.74927004 |
| 158 | Upper limb amyotrophy (HP:0009129) | 1.74816676 |
| 159 | Distal upper limb amyotrophy (HP:0007149) | 1.74816676 |
| 160 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.74405004 |
| 161 | Abnormality of the calf musculature (HP:0001430) | 1.72675907 |
| 162 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.72648370 |
| 163 | Maternal diabetes (HP:0009800) | 1.72537876 |
| 164 | Deep venous thrombosis (HP:0002625) | 1.72477427 |
| 165 | Abnormality of the preputium (HP:0100587) | 1.71598497 |
| 166 | Fatigue (HP:0012378) | 1.71465717 |
| 167 | Broad distal phalanx of finger (HP:0009836) | 1.71172105 |
| 168 | Abnormality of the gallbladder (HP:0005264) | 1.70590084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.17065160 |
| 2 | NME2 | 3.79243468 |
| 3 | VRK2 | 3.07329550 |
| 4 | WEE1 | 2.75652834 |
| 5 | ARAF | 2.61391555 |
| 6 | STK16 | 2.49868025 |
| 7 | OBSCN | 2.45271959 |
| 8 | EIF2AK1 | 2.36962398 |
| 9 | * BCKDK | 2.34300977 |
| 10 | PASK | 2.33095150 |
| 11 | FLT3 | 2.29955671 |
| 12 | LIMK1 | 2.21860912 |
| 13 | BRSK2 | 2.20327237 |
| 14 | SMG1 | 2.19838471 |
| 15 | TLK1 | 2.13005376 |
| 16 | EIF2AK3 | 2.09023064 |
| 17 | MAP2K3 | 2.03804422 |
| 18 | TTN | 1.98553542 |
| 19 | NEK1 | 1.96697665 |
| 20 | PKN2 | 1.94881723 |
| 21 | ERN1 | 1.94282335 |
| 22 | ABL2 | 1.72032458 |
| 23 | MYLK | 1.66082241 |
| 24 | TRIB3 | 1.62673932 |
| 25 | PRPF4B | 1.60871575 |
| 26 | CDC7 | 1.48432827 |
| 27 | MAPKAPK3 | 1.47529991 |
| 28 | ZAP70 | 1.41994797 |
| 29 | CCNB1 | 1.39857713 |
| 30 | RPS6KB2 | 1.38576149 |
| 31 | KDR | 1.37522787 |
| 32 | ZAK | 1.34179733 |
| 33 | VRK1 | 1.30531391 |
| 34 | IRAK4 | 1.29868248 |
| 35 | NME1 | 1.28665020 |
| 36 | RPS6KA4 | 1.27788974 |
| 37 | CDK8 | 1.24046962 |
| 38 | KIT | 1.22065282 |
| 39 | EPHA2 | 1.21788794 |
| 40 | PDK4 | 1.18187444 |
| 41 | PDK3 | 1.18187444 |
| 42 | ICK | 1.17376932 |
| 43 | MOS | 1.17239236 |
| 44 | NEK2 | 1.13698776 |
| 45 | MUSK | 1.12754621 |
| 46 | TGFBR1 | 1.11803036 |
| 47 | PLK1 | 1.11095064 |
| 48 | ILK | 1.10681017 |
| 49 | AURKB | 1.09809861 |
| 50 | BTK | 1.07153746 |
| 51 | BRSK1 | 1.05565576 |
| 52 | SIK1 | 1.05470360 |
| 53 | PAK4 | 1.05101388 |
| 54 | SRPK1 | 1.04630224 |
| 55 | NEK9 | 1.04472513 |
| 56 | ACVR1B | 1.03873187 |
| 57 | DYRK3 | 1.01766794 |
| 58 | IRAK3 | 1.01148219 |
| 59 | MAP3K3 | 1.00361881 |
| 60 | EEF2K | 1.00353699 |
| 61 | PIK3CA | 0.99097558 |
| 62 | EPHB1 | 0.98058265 |
| 63 | PIM2 | 0.96149957 |
| 64 | PRKD2 | 0.96081716 |
| 65 | PIK3CG | 0.96079901 |
| 66 | MAP3K1 | 0.94047807 |
| 67 | LMTK2 | 0.91343743 |
| 68 | TESK2 | 0.90605768 |
| 69 | TSSK6 | 0.90604815 |
| 70 | TAOK1 | 0.90055850 |
| 71 | CSNK1G3 | 0.89596782 |
| 72 | PDK2 | 0.89249163 |
| 73 | TTK | 0.86871439 |
| 74 | DAPK1 | 0.86337452 |
| 75 | BLK | 0.85507532 |
| 76 | BRAF | 0.84508105 |
| 77 | STK4 | 0.83576634 |
| 78 | ATR | 0.82630286 |
| 79 | LRRK2 | 0.81788556 |
| 80 | MAP2K6 | 0.81021450 |
| 81 | CDK7 | 0.80701828 |
| 82 | GRK6 | 0.80655159 |
| 83 | PRKD3 | 0.77736496 |
| 84 | TEC | 0.77309378 |
| 85 | AURKA | 0.74007390 |
| 86 | MAP2K2 | 0.73612535 |
| 87 | SCYL2 | 0.70858404 |
| 88 | TIE1 | 0.69145890 |
| 89 | CDK4 | 0.68827067 |
| 90 | MAP3K11 | 0.67797269 |
| 91 | TBK1 | 0.66845912 |
| 92 | PTK2 | 0.65506230 |
| 93 | MKNK1 | 0.64048950 |
| 94 | JAK3 | 0.63770257 |
| 95 | MAP3K8 | 0.63763053 |
| 96 | AKT2 | 0.63652093 |
| 97 | RPS6KL1 | 0.63279132 |
| 98 | RPS6KC1 | 0.63279132 |
| 99 | RPS6KA6 | 0.62254563 |
| 100 | SIK3 | 0.61048810 |
| 101 | TYK2 | 0.59836976 |
| 102 | TAOK2 | 0.59273002 |
| 103 | TESK1 | 0.58696621 |
| 104 | PHKG2 | 0.57648065 |
| 105 | PHKG1 | 0.57648065 |
| 106 | DDR2 | 0.56857155 |
| 107 | MAP3K10 | 0.56136671 |
| 108 | CAMK2G | 0.55714802 |
| 109 | CSNK1A1L | 0.54919405 |
| 110 | RAF1 | 0.53840246 |
| 111 | CDK11A | 0.53428859 |
| 112 | MAP4K1 | 0.53216116 |
| 113 | PBK | 0.52382558 |
| 114 | CSNK2A1 | 0.52164797 |
| 115 | MKNK2 | 0.50889464 |
| 116 | PTK6 | 0.50305199 |
| 117 | CLK1 | 0.49539585 |
| 118 | CDK14 | 0.49459231 |
| 119 | CDK9 | 0.47976512 |
| 120 | CDK15 | 0.47790355 |
| 121 | DAPK3 | 0.45332670 |
| 122 | BMX | 0.44948450 |
| 123 | STK24 | 0.43662853 |
| 124 | CDK18 | 0.43225877 |
| 125 | PIM1 | 0.42299772 |
| 126 | MAPK11 | 0.41869979 |
| 127 | STK10 | 0.41328811 |
| 128 | MAPKAPK2 | 0.40049708 |
| 129 | RPS6KA5 | 0.38798873 |
| 130 | PRKCI | 0.38457967 |
| 131 | CSNK1G2 | 0.38043403 |
| 132 | PRKG2 | 0.37359948 |
| 133 | MAPKAPK5 | 0.36763682 |
| 134 | CSNK2A2 | 0.35855629 |
| 135 | TGFBR2 | 0.35617181 |
| 136 | PDPK1 | 0.35245431 |
| 137 | RPS6KA2 | 0.34569721 |
| 138 | CDK19 | 0.33276065 |
| 139 | MAPK12 | 0.33158177 |
| 140 | TRPM7 | 0.32588864 |
| 141 | IKBKE | 0.32439129 |
| 142 | PAK1 | 0.31488053 |
| 143 | PRKD1 | 0.31088824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.18635915 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.86465567 |
| 3 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.40576095 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.34839080 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.26753264 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.85914844 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.62216808 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.39592505 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.33000480 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.30712054 |
| 11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.21330256 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.08190892 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.08179323 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.04032540 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.97371598 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95698971 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.93953003 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.82918945 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.82539699 |
| 20 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.79288653 |
| 21 | RNA transport_Homo sapiens_hsa03013 | 1.72141331 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.71099706 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59191947 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57749509 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.54665646 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.52818358 |
| 27 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.50958325 |
| 28 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.30398519 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.30103869 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.29776156 |
| 31 | Huntingtons disease_Homo sapiens_hsa05016 | 1.27291233 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26566397 |
| 33 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.26225307 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.26127923 |
| 35 | RNA degradation_Homo sapiens_hsa03018 | 1.23850433 |
| 36 | Purine metabolism_Homo sapiens_hsa00230 | 1.23425008 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.22283154 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21014638 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.18852403 |
| 40 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18850544 |
| 41 | Galactose metabolism_Homo sapiens_hsa00052 | 1.17422655 |
| 42 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15143992 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14091904 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13121209 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13074329 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06023101 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.04561617 |
| 48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.01446110 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.98576125 |
| 50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96568266 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96482382 |
| 52 | Shigellosis_Homo sapiens_hsa05131 | 0.94415892 |
| 53 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93341267 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.89541301 |
| 55 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.87077977 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86832022 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86801504 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85305282 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.80913675 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.79837637 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.78596975 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77283752 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76781731 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74184067 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73384685 |
| 66 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72206651 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71556587 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71160955 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.71093604 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.70600934 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70483141 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69876544 |
| 73 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66842367 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.66362042 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64773024 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62263173 |
| 77 | Tuberculosis_Homo sapiens_hsa05152 | 0.61492875 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.60766488 |
| 79 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58677624 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.57349493 |
| 81 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.56725955 |
| 82 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56555942 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.56019415 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.56010026 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53260838 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52858160 |
| 87 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51822870 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.51512186 |
| 89 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.50672093 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.50202858 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49553411 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48246911 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47602759 |
| 94 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47314181 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45861135 |
| 96 | Apoptosis_Homo sapiens_hsa04210 | 0.45333900 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44052299 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43992099 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41724302 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41708648 |
| 101 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41178697 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40541731 |
| 103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.39428569 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37889153 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.36698178 |
| 106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.36170605 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35660231 |
| 108 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.32883344 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.32869343 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.32708766 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32374115 |
| 112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.32364603 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.32100272 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.31873706 |
| 115 | Measles_Homo sapiens_hsa05162 | 0.31809898 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.31316322 |
| 117 | Influenza A_Homo sapiens_hsa05164 | 0.31224981 |
| 118 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.29037499 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29021003 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28858445 |
| 121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.28857132 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28622524 |
| 123 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.28124306 |
| 124 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.27665657 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27654171 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25918509 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.24017354 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23596298 |
| 129 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23243743 |
| 130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.22396387 |
| 131 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21613264 |
| 132 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.20876165 |
| 133 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.20724538 |
| 134 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20175224 |
| 135 | Bladder cancer_Homo sapiens_hsa05219 | 0.19044970 |

